<?xml version="1.0" encoding="utf-8"?>
<oembed>
  <version>1</version>
  <type>rich</type>
  <provider_name>Libsyn</provider_name>
  <provider_url>https://www.libsyn.com</provider_url>
  <height>90</height>
  <width>600</width>
  <title>Episode 103: Top trends from NACDS with Leigh O'Donnell</title>
  <description> What did NACDS really reveal this year?  In this Retail Sound Bites episode, Rachel Dalton, Leigh O’Donnell, and Barry Thomas share their candid take on the trends, tensions, and leadership moments shaping drug retail right now.  In this conversation, Rachel Dalton, Leigh O’Donnell, and Barry Thomas look beyond the conference agenda to unpack what NACDS really revealed about the state of drug retail. From the implications of GLP‑1 to how retailers are approaching AI adoption, the role of food as medicine, and the push toward more personalized treatment and experiences for shoppers, the discussion connects macro themes to on‑the‑ground reality.  Want more learnings from NACDS 2026? Access&amp;amp;nbsp;NACDS 2026: Kantar’s top 8 retail healthcare headlines. Have a topic you’d like us to cover? Contact us at&amp;amp;nbsp;Kantar’s Retail Sound Bites Podcast. Contact Barry:&amp;amp;nbsp;Email&amp;amp;nbsp;|&amp;amp;nbsp;LinkedIn Contact Rachel:&amp;amp;nbsp;Email&amp;amp;nbsp;|&amp;amp;nbsp;LinkedIn </description>
  <author_name>Retail Sound Bites</author_name>
  <author_url>https://retailiq.kantar.com/retail-sound-bites</author_url>
  <html>&lt;iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/41074890/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/88AA3C/" height="90" width="600" scrolling="no"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen&gt;&lt;/iframe&gt;</html>
  <thumbnail_url>https://assets.libsyn.com/secure/item/41074890</thumbnail_url>
</oembed>
